SIRNAGEN

At siRNAgen Therapeutics, we believe in a future where patients with immunology and CNS conditions can live healthier longer lives. Using a versatile double conjugate micellar RNAi platform called SAMiRNA, siRNAgen is developing an active pipeline of therapies... siRNAgen Therapeutics, a platform products company, was founded in 2019 as a spinout from Bioneer, one of the world's major oligo manufacturers. The platform was developed based on 20 years of research by Bioneer's leading oligo researchers... siRNAgen Therapeutics is changing the treatment paradigm for patients suffering from chronic inflammatory and CNS conditions with RNAi therapies

Also known as: siRNAgen Therapeutics, siRNAgen Therapeutics Corporation